Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK

K.T. Papazisis, T. Habeshaw, D.W. Miles, R. Leonard, A. Jones, C. Twelves, R. Coleman, A. Makris, H. Earl, M. Highley, C. Price, F. McKinna, T. Perren, J. Le Vay, A. McAleer, S. Houston, M. Crawford, S. Johnston, A. Howell, A. WardleyA. Harris, S. O'Reilly, K. O'Byrne, M. Verrill, T. Hickish, J.L. Mansi, P.J. Barrett-Lee, N. Davidson, R. Stein, C. Rowland, P. Symmonds, N. Bailey, S. Chan, M. Soukop

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science